Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung ...
Leadership
Jennifer L. GoodFounder
Co-Founder, CEO, President, & Director
James V. Cassella Ph.D.
Chief Development Officer
Farrell Simon Pharm.D.
Chief Commercial Officer
Thomas R. Sciascia M.D.Founder
Co-Founder & Chief Scientific Officer
David C. Hastings CPA
Chief Financial Officer & Principal Financial Officer
